Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 466,493 | 688,499 | 659,662 | 437,326 | 1,611,581 |
| Marketable Securities | 572,715 | 422,594 | 732,050 | 234,021 | 191,136 |
| Receivables | 482,797 | 451,480 | 559,332 | 378,807 | 359,518 |
| Inventories | 255,028 | 237,172 | 233,987 | 222,857 | 207,897 |
| Other current assets | 383,995 | 340,730 | 183,376 | 347,459 | 323,874 |
| TOTAL | $2,161,028 | $2,140,475 | $2,368,407 | $1,620,470 | $2,694,006 |
| Non-Current Assets | |||||
| PPE Net | 1,629,398 | 1,581,664 | 1,497,383 | 1,392,577 | 1,330,899 |
| Investments And Advances | 691,044 | 887,069 | 1,133,299 | 1,103,904 | 1,148,033 |
| Intangibles | 3,487,158 | 3,561,445 | 3,629,726 | 3,699,424 | 3,762,777 |
| Other Non-Current Assets | 204,198 | 0 | 0 | 0 | 0 |
| TOTAL | $6,011,798 | $6,030,178 | $6,260,408 | $6,195,905 | $6,241,709 |
| Total Assets | $8,172,826 | $8,170,653 | $8,628,815 | $7,816,375 | $8,935,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 263,711 | 239,535 | 298,881 | 92,336 | 99,440 |
| Accrued Expenses | 471,315 | 400,529 | 367,885 | 386,295 | 346,456 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,990,030 |
| TOTAL | $885,441 | $707,172 | $2,189,175 | $1,988,744 | $3,464,929 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,038,086 | 1,060,448 | 51,843 | 50,113 | 51,348 |
| aiOther Non-Current Liabilities | 223,471 | 344,223 | 331,977 | 226,076 | 193,955 |
| TOTAL | $1,764,454 | $1,930,773 | $905,345 | $834,932 | $834,087 |
| Total Liabilities | $2,649,895 | $2,637,945 | $3,094,520 | $2,823,676 | $4,299,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 290,255 | 293,022 | 297,751 | 293,369 | 287,926 |
| Common Shares | 149 | 149 | 147 | 146 | 172 |
| Retained earnings | -103,137 | -199,204 | -352,169 | -553,080 | -666,955 |
| Other shareholders' equity | 120,719 | 123,220 | 79,246 | 48,127 | -2,958,476 |
| TOTAL | $5,522,931 | $5,532,708 | $5,534,295 | $4,992,699 | $4,636,699 |
| Total Liabilities And Equity | $8,172,826 | $8,170,653 | $8,628,815 | $7,816,375 | $8,935,715 |